KBC Group
TXG icon

KBC Group’s 10x Genomics TXG Stock Holding History

KBC Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Hold
3,714
– – ﹤0.01% 1200
2026
Q1 		$79K Sell
3,714
-1,358
-27% -$27.1K ﹤0.01% 1462
2025
Q4 		$83K Hold
5,072
– – ﹤0.01% 1406
2025
Q3 		$59K Hold
5,072
– – ﹤0.01% 1590
2025
Q2 		$59K Hold
5,072
– – ﹤0.01% 1526
2025
Q1 		$44K Hold
5,072
– – ﹤0.01% 1815
2024
Q4 		$73K Buy
5,072
+1,847
+57% +$29.1K ﹤0.01% 1717
2024
Q3 		$73K Buy
3,225
+902
+39% +$18.6K ﹤0.01% 1498
2024
Q2 		$45K Hold
2,323
– – ﹤0.01% 1682
2024
Q1 		$87K Buy
2,323
+473
+26% +$20.8K ﹤0.01% 1205
2023
Q4 		$104K Hold
1,850
– – ﹤0.01% 1052
2023
Q3 		$76K Buy
+1,850
New +$96.2K ﹤0.01% 1138
2022
Q4 		– Sell
-850
Closed -$24K – 1554
2022
Q3 		$24K Hold
850
– – ﹤0.01% 1501
2022
Q2 		$38K Sell
850
-5,272
-86% -$274K ﹤0.01% 1468
2022
Q1 		$466K Hold
6,122
– – ﹤0.01% 834
2021
Q4 		$912K Buy
6,122
+1,560
+34% +$239K ﹤0.01% 734
2021
Q3 		$664K Hold
4,562
– – ﹤0.01% 816
2021
Q2 		$893K Hold
4,562
– – ﹤0.01% 785
2021
Q1 		$826K Hold
4,562
– – ﹤0.01% 782
2020
Q4 		$646K Buy
+4,562
New +$662K ﹤0.01% 820

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KBC Group's TXG Position: Q2 2026 in Review

KBC Group held its 10x Genomics (TXG) position steady in Q2 2026 at 3,714 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #1200.

KBC Group first reported a position in TXG in Q4 2020 and has held it in 20 quarters since. The position peaked at $912K in Q4 2021. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • KBC Group held 3,714 shares of 10x Genomics worth $142K as of Q2 2026.
  • KBC Group left its 10x Genomics share count unchanged in Q2 2026.
  • 10x Genomics made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #1200 holding.
  • KBC Group first reported a position in 10x Genomics in Q4 2020 and has held it in 20 quarters since.
  • KBC Group's 10x Genomics position peaked at $912K in Q4 2021.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.